These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 19745563)
1. VKORC1 diplotype-derived dosing model to explain variability in warfarin dose requirements in Asian patients. Sandanaraj E; Lal S; Cheung YB; Xiang X; Kong MC; Lee LH; Ooi LL; Chowbay B Drug Metab Pharmacokinet; 2009; 24(4):365-75. PubMed ID: 19745563 [TBL] [Abstract][Full Text] [Related]
2. Association of Vitamin K epoxide reductase complex 1 (VKORC1) variants with warfarin dose in a Hong Kong Chinese patient population. Veenstra DL; You JH; Rieder MJ; Farin FM; Wilkerson HW; Blough DK; Cheng G; Rettie AE Pharmacogenet Genomics; 2005 Oct; 15(10):687-91. PubMed ID: 16141794 [TBL] [Abstract][Full Text] [Related]
3. Validation of a proposed warfarin dosing algorithm based on the genetic make-up of Egyptian patients. Ekladious SM; Issac MS; El-Atty Sharaf SA; Abou-Youssef HS Mol Diagn Ther; 2013 Dec; 17(6):381-90. PubMed ID: 23839801 [TBL] [Abstract][Full Text] [Related]
4. CYP4F2 rs2108622: a minor significant genetic factor of warfarin dose in Han Chinese patients with mechanical heart valve replacement. Cen HJ; Zeng WT; Leng XY; Huang M; Chen X; Li JL; Huang ZY; Bi HC; Wang XD; He YL; He F; Zhou RN; Zheng QS; Zhao LZ Br J Clin Pharmacol; 2010 Aug; 70(2):234-40. PubMed ID: 20653676 [TBL] [Abstract][Full Text] [Related]
5. Allelic variants in the CYP2C9 and VKORC1 loci and interindividual variability in the anticoagulant dose effect of warfarin in Italians. Borgiani P; Ciccacci C; Forte V; Romano S; Federici G; Novelli G Pharmacogenomics; 2007 Nov; 8(11):1545-50. PubMed ID: 18034619 [TBL] [Abstract][Full Text] [Related]
6. Interethnic variability of warfarin maintenance requirement is explained by VKORC1 genotype in an Asian population. Lee SC; Ng SS; Oldenburg J; Chong PY; Rost S; Guo JY; Yap HL; Rankin SC; Khor HB; Yeo TC; Ng KS; Soong R; Goh BC Clin Pharmacol Ther; 2006 Mar; 79(3):197-205. PubMed ID: 16513444 [TBL] [Abstract][Full Text] [Related]
7. Influence of CYP4F2 rs2108622 (V433M) on warfarin dose requirement in Asian patients. Singh O; Sandanaraj E; Subramanian K; Lee LH; Chowbay B Drug Metab Pharmacokinet; 2011; 26(2):130-6. PubMed ID: 21084764 [TBL] [Abstract][Full Text] [Related]
8. Responsiveness to low-dose warfarin associated with genetic variants of VKORC1, CYP2C9, CYP2C19, and CYP4F2 in an Indonesian population. Rusdiana T; Araki T; Nakamura T; Subarnas A; Yamamoto K Eur J Clin Pharmacol; 2013 Mar; 69(3):395-405. PubMed ID: 22855348 [TBL] [Abstract][Full Text] [Related]
9. Effect of CYP2C9 and VKORC1 genotypes on early-phase and steady-state warfarin dosing in Korean patients with mechanical heart valve replacement. Kim HS; Lee SS; Oh M; Jang YJ; Kim EY; Han IY; Cho KH; Shin JG Pharmacogenet Genomics; 2009 Feb; 19(2):103-12. PubMed ID: 19077919 [TBL] [Abstract][Full Text] [Related]
10. Frequency of VKORC1 (C1173T) and CYP2C9 genetic polymorphisms in Egyptians and their influence on warfarin maintenance dose: proposal for a new dosing regimen. El Din MS; Amin DG; Ragab SB; Ashour EE; Mohamed MH; Mohamed AM Int J Lab Hematol; 2012 Oct; 34(5):517-24. PubMed ID: 22533669 [TBL] [Abstract][Full Text] [Related]
11. Factors affecting the interindividual variability of warfarin dose requirement in adult Korean patients. Cho HJ; Sohn KH; Park HM; Lee KH; Choi B; Kim S; Kim JS; On YK; Chun MR; Kim HJ; Kim JW; Lee SY Pharmacogenomics; 2007 Apr; 8(4):329-37. PubMed ID: 17391071 [TBL] [Abstract][Full Text] [Related]
12. Effect of CYP2C9 and VKORC1 genetic variations on warfarin dose requirements in Indian patients. Natarajan S; Ponde CK; Rajani RM; Jijina F; Gursahani R; Dhairyawan PP; Ashavaid TF Pharmacol Rep; 2013; 65(5):1375-82. PubMed ID: 24399734 [TBL] [Abstract][Full Text] [Related]
13. VKORC1 gene variations are the major contributors of variation in warfarin dose in Japanese patients. Obayashi K; Nakamura K; Kawana J; Ogata H; Hanada K; Kurabayashi M; Hasegawa A; Yamamoto K; Horiuchi R Clin Pharmacol Ther; 2006 Aug; 80(2):169-78. PubMed ID: 16890578 [TBL] [Abstract][Full Text] [Related]
14. Influence of CYP2C9 and VKORC1 on warfarin response during initiation of therapy. Limdi NA; Wiener H; Goldstein JA; Acton RT; Beasley TM Blood Cells Mol Dis; 2009; 43(1):119-28. PubMed ID: 19297219 [TBL] [Abstract][Full Text] [Related]
15. Contribution of age, body weight, and CYP2C9 and VKORC1 genotype to the anticoagulant response to warfarin: proposal for a new dosing regimen in Chinese patients. Miao L; Yang J; Huang C; Shen Z Eur J Clin Pharmacol; 2007 Dec; 63(12):1135-41. PubMed ID: 17899045 [TBL] [Abstract][Full Text] [Related]
16. Genetic determinants of warfarin dosing in the Han-Chinese population. Lee MT; Chen CH; Chou CH; Lu LS; Chuang HP; Chen YT; Saleem AN; Wen MS; Chen JJ; Wu JY; Chen YT Pharmacogenomics; 2009 Dec; 10(12):1905-13. PubMed ID: 19958090 [TBL] [Abstract][Full Text] [Related]
17. Factors affecting warfarin dose requirements and quality of anticoagulation in adult Egyptian patients: role of gene polymorphism. Bazan NS; Sabry NA; Rizk A; Mokhtar S; Badary OA Ir J Med Sci; 2014 Jun; 183(2):161-72. PubMed ID: 23800980 [TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of VKORC1 (G-1639A and C1173T) and CYP2C9*3 among patients on warfarin. Teh LK; Langmia IM; Fazleen Haslinda MH; Ngow HA; Roziah MJ; Harun R; Zakaria ZA; Salleh MZ J Clin Pharm Ther; 2012 Apr; 37(2):232-6. PubMed ID: 21507031 [TBL] [Abstract][Full Text] [Related]
19. The impact of genetic polymorphisms and patient characteristics on warfarin dose requirements: a cross-sectional study in Iran. Namazi S; Azarpira N; Hendijani F; Khorshid MB; Vessal G; Mehdipour AR Clin Ther; 2010 Jun; 32(6):1050-60. PubMed ID: 20637959 [TBL] [Abstract][Full Text] [Related]
20. Genetic factors associated with patient-specific warfarin dose in ethnic Indonesians. Suriapranata IM; Tjong WY; Wang T; Utama A; Raharjo SB; Yuniadi Y; Tai SS BMC Med Genet; 2011 Jun; 12():80. PubMed ID: 21639946 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]